[1]
2001. Regional impact of prophylaxis with the monoclonal antibody palivizumab on ospitalizations from respiratory syncytial virus in infants. Swiss Medical Weekly. 131, 1112 (Mar. 2001), 146–151. DOI:https://doi.org/10.4414/smw.2001.09681.